Allyson G Hall1, Jeffrey S Harman, Jianyi Zhang. 1. Department of Health Services Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida 32610, USA. hallag@phhp.ufl.edu
Abstract
BACKGROUND: Gaps in Medicaid coverage can result in inadequate access to care. This can be particularly detrimental to those with a chronic disease such as diabetes. OBJECTIVE: To assess whether a lapse in Medicaid coverage is associated with an increase in expenditures, and acute care utilization upon reenrollment among beneficiaries with diabetes. RESEARCH DESIGN: Using multivariate regression analyses, we compared pre- versus post-expenditures and utilization among 2102 individuals with diabetes who had experienced at least one 1-month lapse in their Medicaid coverage. MEASURES: Dependent variables were the number of inpatient episodes, total length of stay, total number of emergency room visits, total expenditure, and pharmaceutical expenditures. These were aggregated over 3-month spans that either immediately preceded or immediately followed a lapse in coverage. Key predictor variables included a variable that identified the span as occurring pre-lapse or post-lapse in coverage, and a continuous variable identifying the length of the lapse. Predicted expenditure and utilization were calculated. RESULTS: Overall total program expenditures were higher for post-lapse periods compared with pre-lapse periods. Total expenditures were estimated to increase by $239 per member per month for the 3-month period. The likelihood of having any expenditure was actually lower in the post-lapse period. However inpatient and emergency room use was higher. CONCLUSIONS: The results from this study suggest that interruptions in Medicaid coverage are associated with overall greater program expenditures in the post-lapse periods. However, this increase in expenditures seems to be driven by a subset of individuals whose greater use of inpatient and emergency room services increased overall program costs.
BACKGROUND: Gaps in Medicaid coverage can result in inadequate access to care. This can be particularly detrimental to those with a chronic disease such as diabetes. OBJECTIVE: To assess whether a lapse in Medicaid coverage is associated with an increase in expenditures, and acute care utilization upon reenrollment among beneficiaries with diabetes. RESEARCH DESIGN: Using multivariate regression analyses, we compared pre- versus post-expenditures and utilization among 2102 individuals with diabetes who had experienced at least one 1-month lapse in their Medicaid coverage. MEASURES: Dependent variables were the number of inpatient episodes, total length of stay, total number of emergency room visits, total expenditure, and pharmaceutical expenditures. These were aggregated over 3-month spans that either immediately preceded or immediately followed a lapse in coverage. Key predictor variables included a variable that identified the span as occurring pre-lapse or post-lapse in coverage, and a continuous variable identifying the length of the lapse. Predicted expenditure and utilization were calculated. RESULTS: Overall total program expenditures were higher for post-lapse periods compared with pre-lapse periods. Total expenditures were estimated to increase by $239 per member per month for the 3-month period. The likelihood of having any expenditure was actually lower in the post-lapse period. However inpatient and emergency room use was higher. CONCLUSIONS: The results from this study suggest that interruptions in Medicaid coverage are associated with overall greater program expenditures in the post-lapse periods. However, this increase in expenditures seems to be driven by a subset of individuals whose greater use of inpatient and emergency room services increased overall program costs.
Authors: Sarah H Gordon; Yoojin Lee; Chima D Ndumele; Patrick M Vivier; Roee Gutman; Shailender Swaminathan; Emily A Gadbois; Renee R Shield; Amy Jo Haavisto Kind; Amal N Trivedi Journal: Health Serv Res Date: 2018-06-27 Impact factor: 3.402
Authors: Rachel A Wolf; J Sonya Haw; Sudeshna Paul; Melissa Spezia Faulkner; EunSeok Cha; M K Findley; Farah Khan; Sara Markley Webster; Anastasia-Stefania Alexopoulos; Komal Mehta; David A Alfa; Mohammed K Ali Journal: Diabetes Res Clin Pract Date: 2019-09-24 Impact factor: 5.602
Authors: Marguerite E Burns; Laura Dague; Brendan Saloner; Kristen Voskuil; Nam Hyo Kim; Natalia Serna Borrero; Kevin Look Journal: Health Serv Res Date: 2020-06-23 Impact factor: 3.402
Authors: Heather Holderness; Heather Angier; Nathalie Huguet; Jean O'Malley; Miguel Marino; Rachel Springer; Jennifer DeVoe Journal: Med Care Date: 2019-10 Impact factor: 2.983
Authors: Neda Ratanawongsa; Andrew J Karter; Judy Quan; Melissa M Parker; Margaret Handley; Urmimala Sarkar; Julie A Schmittdiel; Dean Schillinger Journal: J Manag Care Spec Pharm Date: 2015-08